We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Type
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (11)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Prescription medicine evaluation (2)
- Cancellation or suspension (1)
Sponsor content
155 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAZKEPA icosapent ethyl 998 mg soft capsule blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAZKEPA icosapent ethyl 998 mg soft capsule bottle.
-
Australian public assessment report (AusPar)Flucelvax Quad (Influenza virus haemagglutinin), a vaccine for the prevention of influenza caused by Influenza Virus Types A and B , has been approved.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Panvax H5N1 Influenza Vaccine.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Inactivated Quadrivalent Influenza Vaccine (Split Virion).
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Australian public assessment report (AusPar)AusPAR for Flucelvax Quad (quadrivalent influenza vaccine) for the prevention of influenza.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bulk Quadrivalent Influenza Vaccine (Split Virion, Inactivated), Thiomersal containing, SH.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IKERVIS ciclosporin 1 mg/mL eye drops emulsion ampoule.